103 related articles for article (PubMed ID: 26845073)
21. Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice.
Sell GL; Xin W; Cook EK; Zbinden MA; Schaffer TB; O'Meally RN; Cole RN; Margolis SS
Sci Rep; 2021 Sep; 11(1):19414. PubMed ID: 34593829
[TBL] [Abstract][Full Text] [Related]
22. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
Godavarthi SK; Dey P; Maheshwari M; Jana NR
Hum Mol Genet; 2012 Apr; 21(8):1824-34. PubMed ID: 22215440
[TBL] [Abstract][Full Text] [Related]
23. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
[TBL] [Abstract][Full Text] [Related]
24. Potential therapeutic approaches for Angelman syndrome.
Bi X; Sun J; Ji AX; Baudry M
Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth.
Bryan B; Cai Y; Wrighton K; Wu G; Feng XH; Liu M
FEBS Lett; 2005 Feb; 579(5):1015-9. PubMed ID: 15710384
[TBL] [Abstract][Full Text] [Related]
26. Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer's disease.
Olabarria M; Pasini S; Corona C; Robador P; Song C; Patel H; Lefort R
Commun Biol; 2019; 2():111. PubMed ID: 30937395
[TBL] [Abstract][Full Text] [Related]
27. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a.
Sato M; Stryker MP
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5611-6. PubMed ID: 20212164
[TBL] [Abstract][Full Text] [Related]
28. Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A.
Sen D; Voulgaropoulos A; Drobna Z; Keung AJ
Stem Cell Reports; 2020 Oct; 15(4):845-854. PubMed ID: 32916124
[TBL] [Abstract][Full Text] [Related]
29. Subcellular organization of UBE3A in neurons.
Burette AC; Judson MC; Burette S; Phend KD; Philpot BD; Weinberg RJ
J Comp Neurol; 2017 Feb; 525(2):233-251. PubMed ID: 27339004
[TBL] [Abstract][Full Text] [Related]
30. A coding-independent function of an alternative Ube3a transcript during neuronal development.
Valluy J; Bicker S; Aksoy-Aksel A; Lackinger M; Sumer S; Fiore R; Wüst T; Seffer D; Metge F; Dieterich C; Wöhr M; Schwarting R; Schratt G
Nat Neurosci; 2015 May; 18(5):666-73. PubMed ID: 25867122
[TBL] [Abstract][Full Text] [Related]
31. Genomic imprinting does not reduce the dosage of UBE3A in neurons.
Hillman PR; Christian SGB; Doan R; Cohen ND; Konganti K; Douglas K; Wang X; Samollow PB; Dindot SV
Epigenetics Chromatin; 2017; 10():27. PubMed ID: 28515788
[TBL] [Abstract][Full Text] [Related]
32. Epilepsy-Associated UBE3A Deficiency Downregulates Retinoic Acid Signalling Pathway.
Fang M; Li Y; Ren J; Hu R; Gao X; Chen L
Front Genet; 2021; 12():681295. PubMed ID: 33995501
[TBL] [Abstract][Full Text] [Related]
33. Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes.
Yang X; Duckhorn J; Marshall J; Huang YA
Exp Neurol; 2024 Jun; 379():114869. PubMed ID: 38901755
[TBL] [Abstract][Full Text] [Related]
34. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
Mulherkar SA; Jana NR
Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
[TBL] [Abstract][Full Text] [Related]
35. UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation.
Rotaru DC; Wallaard I; de Vries M; van der Bie J; Elgersma Y
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810252
[TBL] [Abstract][Full Text] [Related]
36. The effect of alternative neuronal differentiation pathways on PC12 cell adhesion and neurite alignment to nanogratings.
Ferrari A; Faraci P; Cecchini M; Beltram F
Biomaterials; 2010 Mar; 31(9):2565-73. PubMed ID: 20035995
[TBL] [Abstract][Full Text] [Related]
37. Potassium channel dysfunction in human neuronal models of Angelman syndrome.
Sun AX; Yuan Q; Fukuda M; Yu W; Yan H; Lim GGY; Nai MH; D'Agostino GA; Tran HD; Itahana Y; Wang D; Lokman H; Itahana K; Lim SWL; Tang J; Chang YY; Zhang M; Cook SA; Rackham OJL; Lim CT; Tan EK; Ng HH; Lim KL; Jiang YH; Je HS
Science; 2019 Dec; 366(6472):1486-1492. PubMed ID: 31857479
[TBL] [Abstract][Full Text] [Related]
38. Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.
Pastuzyn ED; Shepherd JD
Front Mol Neurosci; 2017; 10():234. PubMed ID: 28804447
[TBL] [Abstract][Full Text] [Related]
39. Detailed Dissection of UBE3A-Mediated DDI1 Ubiquitination.
Elu N; Osinalde N; Beaskoetxea J; Ramirez J; Lectez B; Aloria K; Rodriguez JA; Arizmendi JM; Mayor U
Front Physiol; 2019; 10():534. PubMed ID: 31130875
[TBL] [Abstract][Full Text] [Related]
40. A novel missense mutation of the ubiquitin protein ligase E3A gene in a patient with Angelman syndrome.
Bai JL; Qu YJ; Zou LP; Yang XY; Liu LJ; Song F
Chin Med J (Engl); 2011 Jan; 124(1):84-8. PubMed ID: 21362313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
